JAMDA
February 23, 2017
Showing 1571 - 1580 of 8849 results
JAMDA
June 14, 2025
Central Nervous System Polypharmacy Among People Living With Dementia
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
JAMDA
March 24, 2016
Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia
Most studies assessing the effect of central nervous system (CNS)-acting medicines on cognitive disturbances have focused on the use of individual medicines. The impact on cognitive function when another CNS-acting medicine is added to a patient's treatment regimen is not well known.
JAMDA
August 30, 2021
Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with Worse Outcomes in Dementia
To investigate the associations between central anticholinergic burden and mortality, hospitalization, and cognitive impairment in people with dementia prescribed anticholinergic drugs for urinary symptoms.
JAMDA
February 26, 2019
Cerebral Amyloid Angiopathy Limits Treatment of Stroke
Basic Page
Certification
Are you ready to take your career as a medical director to new heights? Elevate your professional standing and demonstrate your comprehensive understanding of the role by becoming a Certified Medical Director (CMD). This prestigious certification not only showcases your expertise and dedication but also op...
Caring for the Ages
March 17, 2015
Certification Board Chair Talks New Name, New Mission
Basic Page
Certification Fees
JAMDA
December 17, 2014
Certified Nurse Aide Scope of Practice
JAMDA
September 18, 2014